REGISTERED NUMBER: 14319637 (England and Wales)

Mipro Medical Solutions Ltd

Unaudited Financial Statements

for the Year Ended 31 August 2025

Page

Company information

1

Balance sheet

2

Notes to the financial statements

4

Directors:

Dr D M Glover

Dr S Whatmough

Registered office:

28 Huncoat Avenue

Stockport

SK4 5HN

Registered number:

14319637 (England and Wales)

Accountants:

Warr & Co Limited

Chartered Accountants

Mynshull House

78 Churchgate

Stockport

Cheshire

SK1 1YJ

Fixed assets

Intangible assets

4

1,604,665

1,266,142

Tangible assets

5

9,360

691

1,614,025

1,266,833

Current assets

Debtors

6

57,829

176,062

Cash at bank and in hand

341,047

466,344

398,876

642,406

Creditors

Amounts falling due within one year

7

(1,150

)

(1,225

)

Net current assets

397,726

641,181

Total assets less current liabilities

2,011,751

1,908,014

Capital and reserves

Called up share capital

8

14,959

13,455

Share premium

2,429,697

1,920,559

Retained earnings

(432,905

)

(26,000

)

Shareholders' funds

2,011,751

1,908,014

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 26 September 2025 and were signed on its behalf by:

Dr S Whatmough - Director

1.	Statutory information

Mipro Medical Solutions Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	Accounting policies

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements have been prepared on a going concern basis on the grounds that the directors will continue to provide sufficient finance to enable the company to continue trading for the foreseeable future.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of six years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

25% on cost

3.	Employees and directors

The average number of employees during the year was 2 (2024 - 2 ) .

4.	Intangible fixed assets

Development

costs

£

Cost

At 1 September 2024

1,329,049

Additions

659,456

At 31 August 2025

1,988,505

Amortisation

At 1 September 2024

62,907

Amortisation for year

320,933

At 31 August 2025

383,840

Net book value

At 31 August 2025

1,604,665

At 31 August 2024

1,266,142

5.	Tangible fixed assets

Plant and

machinery

etc

£

Cost

At 1 September 2024

922

Additions

11,866

At 31 August 2025

12,788

Depreciation

At 1 September 2024

231

Charge for year

3,197

At 31 August 2025

3,428

Net book value

At 31 August 2025

9,360

At 31 August 2024

691

6.

Debtors: amounts falling due within one year

31.8.25

31.8.24

£

£

Trade debtors

24,000

6,000

Other debtors

-

118,999

VAT

33,829

51,063

57,829

176,062

7.

Creditors: amounts falling due within one year

31.8.25

31.8.24

£

£

Other creditors

1,150

1,225

8.	Called up share capital

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.8.25

31.8.24

value:

£

£

1,495,890

Ordinary

£0.01

14,959

13,455

1,504 Ordinary shares of £0.01 each were allotted as fully paid at a premium of 4.25 per share during the year.